Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-05-31
2005-05-31
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S567000, C514S670000, C514S646000, C548S558000, C544S164000, C560S045000, C562S456000, C564S170000, C564S305000, C564S355000
Reexamination Certificate
active
06900244
ABSTRACT:
The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula I.
REFERENCES:
patent: 4267193 (1981-05-01), Neustadt et al.
patent: 4322434 (1982-03-01), Neustadt et al.
patent: 5011851 (1991-04-01), Meanwell
patent: 5639616 (1997-06-01), Liao et al.
patent: 6316503 (2001-11-01), Li et al.
patent: RE37770 (2002-06-01), Elias et al.
patent: 2001/0018428 (2001-08-01), Zablocki et al.
patent: 2001/0020030 (2001-09-01), Stewart et al.
patent: 2002/0013334 (2002-01-01), Robl et al.
patent: 2002/0016364 (2002-02-01), Luchoomun et al.
patent: 2002/0037872 (2002-03-01), Palle et al.
patent: 2002/0045607 (2002-04-01), Beachy et al.
patent: 2002/0048572 (2002-04-01), Shan et al.
patent: 2002/0120137 (2002-08-01), Houze et al.
patent: 2002/0165394 (2002-11-01), Dumas et al.
patent: 0 135 894 (1985-04-01), None
patent: 0 558 062 (1993-09-01), None
patent: WO 91/00277 (1991-01-01), None
patent: WO 91/00281 (1991-01-01), None
patent: WO 96/19493 (1996-06-01), None
patent: WO 96/34851 (1996-11-01), None
patent: WO 99/19300 (1999-04-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 00/55118 (2000-09-01), None
patent: WO 00/56710 (2000-09-01), None
patent: WO 01/60818 (2001-08-01), None
patent: WO 02/20463 (2002-03-01), None
patent: WO 02/24632 (2002-03-01), None
patent: WO 02/46141 (2002-06-01), None
patent: WO 02/46172 (2002-06-01), None
patent: WO 02/46181 (2002-06-01), None
patent: WO 02/058690 (2002-08-01), None
Cas Registry No. 329915-55-1.
Chkanikov et al., “Hexafluoroacetone and Methyl Trifluoropyruvate as Precursors of Modified Esters of N-Acyl-N-Phenyl or Amino Acids”; 1993, pp. 1415-1424, Plenum Publishing Corporation.
International Search Report, PCT/US 03/16382; 6 sheets.
Chkanikov, et al., “Hexafluoroacetone and Methyl Trifluoropyruvate as Precursors of Modified Esters of N-acyl-N-phenyl-.alpha.-amino acids” Cas Registry No. 147749-06-2 (Database Accession No. 118:255272 XP002253208).
International Preliminary Examination Report, dated Mar. 30, 2004 (5 pages).
Collins Joe T.
DeCrescenzo Gary A.
Kalman Monica J.
Malecha James W.
Miyashiro Julie M.
Benson Gregg C.
Dentz Bernard
Pharmacia Corporation
Richardson Peter C.
Samuels Lisa A.
LandOfFree
Anilino liver X-receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anilino liver X-receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anilino liver X-receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3446020